The extracellular matrix in oral squamous cell carcinoma: Friend or foe?

Head and Neck

Volumn 28, Issue 8, 2006, Pages 740-749

  Ziober, Amy F ^a   Falls, Erica M ^a   Ziober, Barry L ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Collagen; Extracellular matrix; Head and neck cancer; Invasion; Laminin; Metastasis; Squamous cell carcinoma

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 11; COLLAGEN TYPE 17; COLLAGEN TYPE 4; COLLAGEN TYPE 5; COLLAGEN TYPE 7; FIBRONECTIN; KALININ; LAMININ 10; LAMININ 11; LAMININ 6; UNCLASSIFIED DRUG;

CANCER GROWTH; CANCER INVASION; DISEASE COURSE; EXTRACELLULAR MATRIX; GENE OVEREXPRESSION; HUMAN; LYMPH NODE METASTASIS; MOUTH CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CELL ADHESION MOLECULES; CELL MOVEMENT; COLLAGEN; DISEASE PROGRESSION; EXTRACELLULAR MATRIX; HUMANS; KERATINOCYTES; LYMPHATIC METASTASIS; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASMS, SQUAMOUS CELL;

EID: 33746344387     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20382     Document Type: Review

References (80)

1. Shingaki S. et al. Impact of lymph node metastasis on the pattern of failure and survival in oral carcinomas. Am J Surg 2003;185:278-284.
2. Albelda SM, Buck CA. Integrins and other cell adhesion molecules. FASEB J 1990;4:2868-2880.
3. Ginsberg MH, Loftus JC, D'Souza S, Plow EF. Ligand binding to integrins: common and ligand specific recognition mechanisms. Cell Differ Dev 1990;32:203-214.
4. Cheresh DA. Structural and biologic properties of integrin-mediated cell adhesion. Clin Lab Med 1992;12:217-236.
5. Bosman FT. Integrins: cell adhesives and modulators of cell function. Histochem J 1993;25:469-477.
6. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992;69:11-25.
7. Ziober BL, Silverman SS Jr, Kramer R. Adhesive mechanisms regulating invasion and metastasis in oral cancer. Crit Rev Oral Biol Med 2001;12:499-510.
8. Garrone R, Lethias C, Guellec DL. Distribution of minor collagens during skin development. Microsc Res Tech 1997;38:407-412.
9. Stenbeack F, Maelinen MJ, Jussila T, et al. The extracellular matrix in skin development: a morphological study. J Cutan Pathol 1997;26:327-338.
10. Hagedorn H, Schreiner M, Weist I, Teubel J, Schleicher ED, Nerlich AG. Defective basement membrane in laryngeal carcinomas with heterozygous loss of distinct components. Hum Pathol 1998;29:447-454.
11. Sok JC, Kuriakose MA, Mahajan VB, Pearlman AN, DeLacure MD, Chen FA. Tissue-specific gene expression of head and neck squamous cell carcinoma in vivo by complementary DNA microarray analysis. Arch Otolaryngol Head Neck Surg 2003;129:760-770.
12. Schmalbach CE, Chepeha DB, Giordano T, et al. Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2004;130:295-302.
13. Franzke CW, Tasanen K, Schumann H, Bruckner-Tuderman L. Collagenous transmembrane proteins: collagen XVII as a prototype. Matrix Biol 2003;22:299-309.
14. Ortiz-Urda S, Garcia J, Green CL, et al. Type VII collagen is required for Ras-driven human epidermal tumorigenesis. Science 2005;307:1773-1776.
15. Parrika M, Kainulainen T, Tasanen K, Vaanen A, Bruckner-Tuderman L, Salo T. Alterations of collagen XVII expression during transformation of oral epithelium to dysplasia and carcinoma. J Histochem Cytochem 2003;51:921-929.
16. Tasanen K, Tunggal L, Chometon G, Bruckner-Tuderman L, Aumailley M. Keratinocytes from patients lacking collagen XVII display a migratory phenotype. Am J Pathol 2004;164:2027-2038,
17. Guo W, Giancotti FG. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 2004;5:816-826.
18. Harada T, Shinohara M, Nakamura S, Oka M. An immunohistochemical study of the extracellular matrix in oral squamous cell carcinoma and its association with invasive and metastatic potential. Virchows Arch 1994;424:257-266.
19. Kosmel H, Berndt A, Strassburger S, et al. Distribution of laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma. Br J Cancer 1999;81:1071-1079.
20. Mhawech P, Dulguerov P, Assaly M, Ares C, Allal AS. EBD fibronectin expression in squamous cell carcinoma of the head and neck. Oral Oncol 2005;41:82-88.
21. Zhang Y, Lu H, Dazin P, Kapila Y. Squamous cell carcinoma cell aggregates escape suspension-induced, p53-mediated anoikis: fibronectin and intregrin alphav mediate survival signals through focal adhesion kinase. J Biol Chem 2004;279:58342-58349.
22. Colognato H, Yurchenco PD. Form and function: the laminin family heterotrimers. Dev Dynam 2002;218:213-234.
23. Miner JH, Yurchenco PD. Laminin functions in tissue morphogenesis. Annu Rev Cell Dev Biol 2004;20:255-284.
24. Kikkawa Y, Sanzen N, Fujiwara H, Sonnenberg A, Sekiguchi K. Integrin binding specificity of laminin-10/11: laminin-10/11 are recognized by alpha 3 beta 1, alpha 6 beta 1 and alpha 6 beta 4 integrins. J Cell Sci 2000;113:869-876.
25. Rousselle P, Aumailley M. Kalinin is more efficient than laminin in promoting adhesion of primary keratinocytes and some other epithelial cells and has a different requirement for integrin receptors. J Cell Biol 1994;125:205-214.
26. Goldfinger LE, Hopkinson SB, deHart GW, Collawn S, Couchman JR, Jones JCR. The α3 laminin subunit, α6β4 and α3β1 integrin coordinately regulate wound healing in cultured epithelial cells and in the skin. J Cell Sci 1999;112:2615-2629.
27. Koshikawa N, Giannelli G, Cirulli V, Miyazaki K, Quaranta V. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J Cell Biol 2000;148:615-624.
28. Ebihara N, Mizushima H, Miyazaki K, Watanabe K, Ikawa S, Nakayasu K, Kanai A. The functions of exogenous and endogenous laminin-5 on corneal epithelial cells. Exp Cell Res 2000;71:69-79.
29. Lohi J. Laminin-5 in the progression of carcinomas. Int J Cancer 2001;94:763-767.
30. Gagnoux-Palacios L, Allegra M, Spirito F, et al. The short arm of the laminin γ2 chain plays a pivotal role in the incorporation of laminin 5 into the extracellular matrix and in cell adhesion. J Cell Biol 2001;153:835-849.
31. McGowan K, Veitch D, Findell P, Russell A, Ho WB, Marinlovich MP. Bmp-1 processing of laminin-5 controls migration of human epithelial cells [abstract]. Annual Meeting of the Society of Investigative Dermatology. 2000.
32. Clark EA, Eng WG, Brugge JS, Symons M, Hynes RO. Integrin-mediated signals regulated by members of the rho family of GTPases. J Cell Biol 1998;142:573-586.
33. Thorup AK, Reibel J, Schiodt M, et al. Can alterations in integrin and laminin-5 expression be used as markers of malignancy? APMIS 1998;106:1170-1180.
34. Yuen HW, Ziober AF, Gopal P, et al. Suppression of laminin-5 expression leads to increased motility, tumorigenicity, and invasion. Exp Cell Res 2005 [Epub ahead of print].
35. Ferletta M, Ekblom P. Identification of laminin-10/11 as a strong cell adhesive complex for a normal and a malignant human epithelial cell line. J Cell Sci 1999;112:110.
36. Pouliot N, Saunders NA, Kaur P. Laminin 10/11: an alternative adhesive ligand for epidermal keratinocytes with a functional role in promoting proliferation and migration. Exp Dermatol 2002;11:387-397.
37. Pyke C, Romer J, Kallunki P, et al. The gamma 2 chain of kalinin/laminin-5 is preferentially expressed in invading malignant cells in human cancers. Am J Pathol 1994;145:782-791.
38. Pyke C, Salo S, Ralfkialer E, Romer J, Dano K, Tryggvason K. Laminin-5 is a marker of invading cancer cells in some human carcinomas and coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. Cancer Res 1995;55:4132-4139.
39. Koshikawa N, Moriyama K, Takamura H, et al. Overexpression of laminin γ2 chain monomer in invading gastric carcinoma cells. Cancer Res 1999;59:5596-5601.
40. Skyldberg B, Salo S, Eriksson E, et al. Laminin-5 as a marker of invasiveness in cervical lesions. J Natl Cancer Inst 1999;91:1882-1887.
41. Lenander C, Habermann JK, Ost A, et al. Laminin-5 gamma 2 chain expression correlates with unfavorable prognosis in colon carcinomas. Anal Cell Pathol 2001;22:201-209.
42. Ono Y, Nakanishi Y, Ino Y, et al. Clinocopathologic significance of laminin-5 gamma2 chain expression in squamous cell carcinoma of the tongue: immunohistochemical analysis of 67 lesions. Cancer 1999;85:2315-2321.
43. Katoh K, Nakanishi Y, Akimoto S, et al. Correlation between laminin-5 gamma2 chain expression and epidermal growth factor receptor expression and its clinicopathological significance in squamous cell carcinoma of the tongue. Oncology 2002;62:318-326.
44. Ono Y, Nakanishi Y, Gotoh M, Sakamoto M, Hirohashi S. Epidermal growth factor receptor gene amplification is correlated with laminin-5 gamma2 chain expression in oral squamous cell carcinoma cell lines. Cancer Lett 2002;75:197-204.
45. Nakayama M, Sato Y, Okamoto M, Hirohashi S. Increased expression of laminin-5 and its prognostic significance in hypopharyngeal cancer. Laryngoscope 2004;114:1259-1263.
46. Katayama M, Sekiguchi K. Laminin-5 in epithelial tumour invasion. J Mol Histol 2004;35:277-286.
47. Kagesato Y, Mizushima H, Koshikawa N, et al. Sole expression of laminin gamma 2 chain in invading tumor cells and its association with stromal fibrosis in lung adenocarcinomas. J Cancer Res 2001;92:184-192.
48. Yamamoto H, Itoh F, Iku S, Hosokawa M, Imai K. Expression of the gamma(2) chain of laminin-5 at the invasive front is associated with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Clin Cancer Res 2001;7:896-900.
49. Olsen J, Kirkeby LT, Brorsson MM, et al. Converging signals synergistically activate the LAMC2 promoter and lead to accumulation of the laminin gamma 2 chain in human colon carcinoma cells. Biochem J 2003;371:211-221.
50. Decline F, Rousselle P. Keratinocyte migration requires alpha2beta1 integrin-mediated interaction with the laminin 5 gamma2 chain. J Cell Sci 2001;114:811-823.
51. Goldfinger LE, Stack MS, Jones JC. Processing of laminin-5 and its functional consequences: role of plasmin and tissue-type plasminogen activator. J Cell Biol 1998;141:255-265.
52. Giannelli G, Milillo L, Marinosci F, Lo Muzio L, Serpico R, Antonaci S. Altered expression of integrins and basement membrane proteins in malignant and pre-malignant lesions of oral mucosa. J Biol Regul Homeost Agents 2001;15:375-380.
53. Larjava H, Salo T, Haapasalmi K, Kramer RH, Heino J. Expression of integrins and basement membrane components by wound keratinocytes. J Clin Invest 1993;92:1425-1435.
54. Dyce OH, Ziober AF, Weber RS, et al. Integrins in head and neck squamous cell carcinoma invasion. Laryngoscope 2002;112:2025-2032.
55. Nordemar S, Hogmo A, Lindholm J, Auer G, Munck-Wilkland E. Laminin-5 gamma 2: a marker to identify oral mucosal lesions at risk for tumor development? Anticancer Res 2003;23:4985-4989.
56. Ziober BL, Chen Y, Kramer RH. The laminin-binding activity of the alpha 7 integrin receptor is defined by developmentally regulated splicing in the extracellular domain. Mol Biol Cell 1997;8:1723-1734.
57. Hintermann E, Quaranta V. Epithelial cell motility on laminin-5: regulation by matrix assembly, proteolysis, integrins and erbB receptors. Matrix Biol 2004;23:75-85.
58. Nguyen BP, Ryan MC, Gil SG, Carter WG. Deposition of laminin-5 in epidermal wounds regulates integrin signaling and adhesion. Curr Opin Cell Biol 2000;12:554-562.
59. Frank DE, Carter WG. Laminin 5 deposition regulates keratinocyte polarization and persistent migration. J Cell Sci 2004;117:1351-1363.
60. Tunggal L, Ravaux J, Pesch M, et al. Defective laminin 5 processing in cylindroma cells. Am J Pathol 2001;160:459-468.
61. O'Toole EA, Marinkovich MP, Peavey CL, et al. Hypoxia increases human keratinocyte motility on connective tissue. J Clin Invest 1997;100:2881-2891.
62. Esco MA, Wang Z, McDermott ML, Kurpakus-Wheater M. Potential role for laminin 5 in hypoxia-mediated apoptosis of human corneal epithelial cells. J Cell Sci 2001;114:4033-4040.
63. Ryan MC, Lee K, Miyashita Y, Carter WG. Targeted disruption of the LAMA3 gene in mice reveals abnormalities in survival and late stage differentiation of epithelial cells. J Cell Biol 1999;145:1309-1323.
64. Van Waes C, Kozarsky KF, Warren AB, et al. The antigen A9 associated with aggressive human squamous carcinoma is structurally and functionally similar to the newly defined integrin alpha 6 beta 4. Cancer Res 1991;51:2395-2402.
65. Choma DP, Pumiglia K, DiPersio CM. Integrin alpha3 beta1 directs the stabilization of a polarized lamellipodium in epithelial cells through activation of Rac1. J Cell Sci 2004;117:3947-3959.
66. Kainulainen T, Hakkinen L, Hamidi S, et al. Laminin-5 expression is independent of the injury and the microenvironment during reepithelialization of wounds. J Histochem Cytochem 1999;46:353-360.
67. Salo S, Haakana H, Kontusaari S, Hujanen E, Kallunki T, Tryggvason K. Laminin-5 promotes adhesion and migration of epithelial cells: identification of a migration-related element in the gamma2 chain gene (LAMC2) with activity in transgenic mice. Matrix Biol 1999;18:197-210.
68. Kawano K, Kantak SS, Murai M, Yao CC, Kramer RH. Integrin alpha3beta1 engagement disrupts intercellular adhesion. Exp Cell Res 2001;262:180-196.
69. Zhang F, Tom CC, Kugler MC, et al. Distinct ligand binding sites in integrin alpha3 beta1 regulate matrix adhesion and cell-cell contact. J Cell Biol 2003;163:177-188.
70. Murai S, Umemiya T, Seiki M, Harigaya K. Expression and localization of membrane-type-1 matrix metalloproteinase, CD 44, and laminin-5 gamma2 chain during colorectal carcinoma tumor progression. Virchows Arch 2004. [Epub ahead of print].
71. Margulis A, Andriani F, Fusenig N, Hashimoto K, Hanakawa Y, Garlick JA. Abrogation of E-cadherinmediated adhesion induces tumor cell invasion in human skin-like organotypic culture. J Invest Dermatol 2003;121:1182-1190.
72. Hornebeck W, Maquart FX. Proteolyzed matrix as a template for the regulation of tumor progression. Biomed Pharmacother 2003;57:223-230.
73. Maquart FX, Bellon G, Pasco S, Monboisse JC. Matrikines in the regulation of extracellular matrix degradation. Biochimie 2005;87:353-360.
74. Tsubota Y, Mizushima H, Hirosaki T, Higashi S, Yasumitsu H, Miyazaki K. Isolation and activity of proteolytic fragment of laminin-5 alpha3 chain. Biochem Biophys Res Commun 2000;278:614-620.
75. Nikitakis NG, Rivera H, Lopes MA, et al. Immunohistochemical expression of angiogenesis-related markers in oral squamous cell carcinomas with multiple metastatic lymph nodes. Am J Clin Pathol 2003;119:574-586.
76. Somoza-Martin JM, Garcia-Garcia A, Barros-Angueira F, et al. Gene expression profile in oral squamous cell carcinoma: a pilot study. J Oral Maxillofac Surg 2005;63:786-792.
77. O'Donnell RK, Kupferman M, Wei SJ, et al. Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity. Oncogene 2005;24:1244-1251.
78. Wang H, Fu W, Im JH, et al. Tumor cell alpha3beta1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis. J Cell Biol 2004;164:935-941.
79. Jin H, Varner J. Integrins: roles in cancer development and as treatment targets. Br J Cancer 2004;90:561-565.
80. Wickstrom SA, Alitalo K, Keski-Oja J. Endostatin signaling and regulation of endothelial cell-matrix interactions. Adv Cancer Res 2005;94:197-229.